|
ZNFX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.319000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.445400E-01 |
| Normal-vs-Stage2 |
2.151000E-01 |
| Normal-vs-Stage3 |
1.173400E-01 |
| Normal-vs-Stage4 |
4.116500E-02 |
| Stage1-vs-Stage2 |
6.949000E-01 |
| Stage1-vs-Stage3 |
4.925400E-01 |
| Stage1-vs-Stage4 |
2.652200E-01 |
| Stage2-vs-Stage3 |
9.202200E-01 |
| Stage2-vs-Stage4 |
5.785400E-01 |
| Stage3-vs-Stage4 |
5.898400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.168000E-01 |
| Normal-vs-AfricanAmerican |
7.159400E-01 |
| Normal-vs-Asian |
6.820800E-01 |
| Caucasian-vs-AfricanAmerican |
6.192000E-01 |
| Caucasian-vs-Asian |
5.172400E-01 |
| AfricanAmerican-vs-Asian |
9.972600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.823600E-02 |
| Normal-vs-Female |
1.837810E-01 |
| Male-vs-Female |
4.739600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.108200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.919600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.816400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.613790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.915800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.318300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.653400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.097010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.128800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.347600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.565840E-01 |
| Classical-VS-Follicular |
5.82159997986054E-09 |
| Classical-VS-Other |
1.587870E-02 |
| Classical-VS-Normal |
8.920400E-01 |
| Tall-VS-Follicular |
3.251500E-02 |
| Tall-VS-Other |
1.013840E-01 |
| Tall-VS-Normal |
1.706040E-01 |
| Follicular-VS-Other |
6.118800E-01 |
| Follicular-VS-Normal |
2.22099999999115E-05 |
| Other-VS-Normal |
9.999800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.540400E-02 |
| Normal-vs-N1 |
2.574200E-02 |
| N0-vs-N1 |
3.895400E-01 |
|
|
